The proven software platform for cell and gene therapy supply chain management

Vineti’s PTM® platform is essential enterprise software to drive and scale global personalized therapies, such as cell therapies, gene therapies, and cancer vaccines. PTM® connects the right patient to the right product, on time and on track. See why Vineti is a World Economic Forum Technology Pioneer.
Man holding tablet

Personalized Therapy Management®

Vineti’s essential enterprise platform to drive and scale global advanced therapies, including cell therapies, gene therapies, and cancer vaccines
PTM Enterprise™
PTM Essentials™

Enterprise

PTM Enterprise™ – the complete end-to-end enterprise-grade software solution to industrialize and scale advanced therapies, ensuring standards, patient safety, data security, regulatory compliance, and a seamless customer experience

laptop ordering example
Safe
Secure
Seamless
Scalable

Essentials

PTM Essentials™ – the purpose-built solution that accelerates advanced therapy clinical trials, helping studies start up quickly and run simply and scaling alongside your trial

laptop screen
Faster
Proven
Simple

Integrations

Whether you have one system to connect or many, Vineti integrates critical systems to bring the workflow together — EBR, ERP, MES, IWRS, CRM, 3PL, SSO and more …

Leading industry-wide global footprint

Hospital
200+ Hospitals + Clinics
shield with checkbox
40k+ Testing Hours
geometric globe icon
20+ Countries
Person icon
4500+ CGT Treatments

Orchestrating our ecosystem

CAH
mavens
eversana
avobis bio
oncobay
PRA Health Sciences

Kite Pharma and Vineti enter strategic partnership to develop best-in-class logistics and data analytics software for engineered T-cell therapies at commercial scale

Vineti partners with World Courier to provide a state-of-the-art supply chain solution for global cell and gene therapy ecosystem

Deloitte and Vineti will team up on an end-to-end solution to support personalized medicine

Vineti and Quick Specialized Healthcare Logistics partner to share industry expertise that helps strengthen cell and gene therapy supply chains

Vineti™ to partner with Tessa Therapeutics™ to advance and scale cancer immunotherapies world-wide

Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS (announcement includes work with Vineti)

Lonza partners with Vineti across its cell and gene therapy manufacturing network to optimize ‘vein-to-vein’ delivery service

Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market

Vineti and WuXi AppTec Advanced Therapies Collaborate to Simplify Manufacturing Supply Chain for Advanced Therapies

Vineti Completes $35 Million in Series C Financing to Industrialize Personalized and High-Value Therapeutics

Together, Cardinal Health and Vineti offer integrated, innovative solutions for advanced therapies, helping pharma companies realize faster speed to market, reduced risk, and a more consistent customer experience.

Mavens’ Cell & Gene Navigator, built on Salesforce Health Cloud, supports cutting-edge concierge services that power patient services hubs for specialty pharma and rare disease, and will seamlessly integrate with Vineti’s personalized therapy management solution.

Integrated Commercial Services and Personalized Therapy Management system to seamlessly track product and patient journey

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions

Integrated Custom-Curated IO Clinical Trial Services and Personalized Therapy Management systems to seamlessly manage advanced therapy clinical journeys for cancer patients

Vineti and Marker Therapeutics announce strategic partnership to support diverse cell therapy portfolio

Vineti and OriBiotech announce a partnership to produce a fully pre-integrated solution to modernize, fast-track, and streamline the manufacture and delivery of cell and gene therapies.

Vineti and PRA Health Sciences announce a strategic relationship to support the operational challenges associated with autologous, allogeneic, and personalized therapeutics in cell and gene therapy (CGT) clinical trials.

Körber and Vineti announce a partnership to provide improved manufacturing performance and visibility globally for cell and gene-based therapies.

In the spotlight

Subscribe now to get the latest updates

pink background